News | June 03, 2015

Percutaneous Cardiovascular Solutions Granted Key U.S. Patent for Mitral Valve Replacement Device

Patent covers percutaneous valve replacement as well as delivery method and implantation

June 3, 2015 - Percutaneous Cardiovascular Solutions (PCS) announced it had been granted a key patent in the United States covering its percutaneous mitral valve replacement system.

United States of America Patent No. 8979922, entitled "˜Mitral Valve Prosthesis', covers the use of a percutaneous mitral valve replacement system which enables patients with severe mitral regurgitation and failing hearts to have a catheter-based minimally invasive option for valve replacement. The allowed claims include percutaneous replacement of the mitral valve, including sub-valvular fixation, as well as the method of delivery and implantation. Similar patent claims have been granted in other jurisdictions.

According to Elsevier Business Intelligence, significant mitral valve regurgitation occurs in about 2 percent of the population, with approximately 4 million people in the United States with moderate to severe mitral regurgitation. The potential market for percutaneous mitral valve repair or replacement is expected to be at least four times greater than the aortic valve replacement market.

For more information:

Related Content

Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology| September 05, 2017
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to...
World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy
News | Heart Valve Technology| August 31, 2017
NaviGate Cardiac Structures Inc. (NCSI) announced that its Gate catheter-guided tricuspid atrioventricular valved stent...
Sponsored Content | Videos | Heart Valve Technology| August 30, 2017
Azeem Latib, M.D., MBBCh, FCP, interventional cardiologist at Columbus Hospital in Milan, Italy, discusses the latest
PinnacleHealth First in Pennsylvania to Implant Sentinel Cerebral Protection System
News | Embolic Protection Devices| August 23, 2017
PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to introduce new technology...
CMS Awards New Technology Add-on Payment for Perceval Sutureless Aortic Heart Valve
News | Heart Valve Technology| August 22, 2017
August 22, 2017 — LivaNova PLC announced its Perceval ...
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Overlay Init